These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11167926)

  • 1. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
    Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair JC; Camacho-Hübner C; Miraki Moud F; Rosberg S; Burren C; Lim S; Clayton PE; Bjarnason R; Albertsson-Wikland K; Savage MO
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone.
    Ahmed ML; Foot AB; Edge JA; Lamkin VA; Savage MO; Dunger DB
    Acta Paediatr Scand; 1991 Apr; 80(4):446-50. PubMed ID: 2058394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short stature in Noonan syndrome: response to growth hormone therapy.
    Kirk JM; Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Price DA; Wilton P; Group tU
    Arch Dis Child; 2001 May; 84(5):440-3. PubMed ID: 11316696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
    Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
    Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
    Soliman AT; El Banna N; Ansari BM
    Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
    Smyczynska J; Hilczer M; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.
    Gill MS; Whatmore AJ; Tillman V; White A; Addison GM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):483-92. PubMed ID: 9196612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.